EUCTR2012-002211-25-NO进行中（未招募）不适用
Prevention of bladder dysfunction in acute spinal cord injury A double-blind, randomized, placebo-controlled study to explore the effect of early treatment with Onabotulinumtoxin A in patients with detrusor overactivity due to spinal cord injury
Oslo University Hospital, Dept of Urology0 个研究点开始时间: 2012年10月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Acute spinal cord injury within 4 weeks of the trial
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •No former neurological disease
- •Not willing to give informed consent
- •Age below 18 years
研究者
相似试验
已完成
4 期
Prevention of Bladder Dysfunction in Acute Spinal Cord InjurySpinal Cord InjuriesUrinary Bladder, OveractiveNCT01698138Oslo University Hospital20
已完成
不适用
Prevention of lower urinary tract symptoms in elderly males: the effects of an increased urine output on symptoms and bladder functioningProstate Cancer, Lower Urinary Tract Symptoms (LUTS)Urological and Genital DiseasesOther symptoms and signs involving the urinary systemISRCTN91699014niversity Maastricht (UM) (The Netherlands)141
已完成
不适用
Development of a manual to guide care for people with incontinence to prevent or treat incontinence associated dermatitis (sore skin), Part 1 and 2ISRCTN26169429King's College London23
进行中（未招募）
不适用
Development of a manual to guide care for people with incontinence to prevent or treat incontinence associated dermatitis (sore skin), part 3Incontinence-associated dermatitisSkin and Connective Tissue DiseasesDermatitisISRCTN70866724King's College London288
进行中（未招募）
2 期
Bladder Preservation Therapy in combination with Atezolizumab and Radiation Therapy for invasive bladder cancer, a phase II, open-label, multicenter studyBladder cancerJPRN-jRCT2031180060ishiyama Hiroyuki45